Cubist Systematic Strategies, LLC Assertio Holdings, Inc. Transaction History

Cubist Systematic Strategies, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.02 - $2.57 $34,289 - $86,395	33,617 New	33,617 $35,000
Q2 2023 Aug 14, 2023	SELL	$5.0 - $7.66 $449,990 - $689,384	-89,998 Reduced 54.1%	76,357 $413,000
Q1 2023 May 15, 2023	BUY	$3.54 - $6.66 $445,066 - $837,328	125,725 Added 309.44%	166,355 $1.06 Million
Q4 2022 Feb 14, 2023	BUY	$2.11 - $4.3 $61,325 - $124,975	29,064 Added 251.29%	40,630 $174,000
Q3 2022 Nov 14, 2022	SELL	$2.13 - $4.0 $140,277 - $263,432	-65,858 Reduced 85.06%	11,566 $26,000
Q3 2022 Nov 14, 2022	SELL	$2.13 - $4.0 $140,277 - $263,432	-65,858 Reduced 85.06%	11,566 $26,000
Q2 2022 Aug 15, 2022	BUY	$1.88 - $3.42 $18,339 - $33,362	9,755 Added 14.42%	77,424 $228,000
Q1 2022 May 16, 2022	BUY	$2.06 - $3.0 $69,306 - $100,932	33,644 Added 98.88%	67,669 $194,000
Q4 2021 Feb 14, 2022	BUY	$0.86 - $2.3 $29,261 - $78,257	34,025 New	34,025 $74,000

114

37.2M

755K

39.5K

Ticker ASRT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 48,178,200
Market Cap $58.8M
Description
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.